UNSPSC 51131644: Melagatran

This classification denotes an anticoagulant agent with the molecular formula C22H31N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2A9QP32MD4, chemically known as glycine, n-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (s-(r*,s*))- but generally known as melagatran, which bears US NIH Compound Identifier 183797. European Medicines Agency schedules Melagatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08718MIG.

UNSPSC 51131644 Melagatran is a Commodity code, but the recent state and local procurement activity tagged under it does not reflect pharmaceutical procurement — instead, the sole recent opportunity shows a mismatch between the code assignment and the actual work being solicited. Sourcewell, the State of Minnesota's local government unit and service cooperative, posted RFP #061626 on May 12, 2026 to establish a cooperative purchasing contract for law enforcement equipment on behalf of participating entities across multiple states and Canadian jurisdictions, with proposals due June 16, 2026. The solicitation spans county governments (Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington), municipalities, school districts, higher education institutions, tribal governments, and nonprofit organizations. No specific dollar values, set-asides, or incumbent vendors are identified in the available documentation.

The code shows minimal relevant recent activity, with the single posted opportunity appearing to be miscoded — the law enforcement equipment procurement bears no relationship to melagatran (an anticoagulant medication) or pharmaceutical procurement generally. Geographic activity in the source is concentrated in Washington state counties and extends nationwide through Sourcewell's cooperative purchasing model, but this reflects the law enforcement equipment solicitation rather than actual melagatran procurement. Firms evaluating this code should treat it as showing little current state and local pharmaceutical purchasing activity; the mismatch between code name and posted opportunity suggests either a data entry error in the coding system or that melagatran procurement through state and local channels is currently inactive.